The headlines will tell you that stopping a GLP-1 means gaining the weight back. And they're right. A study of 77,000 patients confirms it: stop the drug, and the weight returns within a year to a year and a half. But Vincent Catalano isn't sure that's the problem everyone is making it out to be.

In this solo episode, Vincent connects his own 23-year experience taking atorvastatin to manage cholesterol with the growing reality that some people will take GLP-1s indefinitely to manage their weight. The same logic applies: if the drug works, if the price is manageable, and if it keeps a larger health problem in check, why is lifetime use a bad thing?

With pill-form GLP-1s dropping to around $200 a month and prices expected to fall further, Vincent walks through the math: $200 a month is two dinners out. For someone managing obesity and its downstream health risks, that may be one of the most cost-effective decisions available.

About Vincent Catalano: Vincent Catalano brings over 23 years of employee benefits experience as an independent consultant and host of The CLEARly Beneficial Podcast. His unique position outside corporate constraints allows him to have frank conversations about healthcare issues that others in the industry cannot address.

This episode is brought to you by HealthNEXT. HealthNEXT partners with employers to transform their employee health benefits through innovative, results-driven solutions that prioritize both cost savings and improved health outcomes.

Disclaimer: The information provided in this podcast is for educational and informational purposes only and should not be construed as legal, financial, or professional advice. Listeners should consult with qualified professionals regarding their specific situation.

Subscribe & Connect

YouTube: @CLEARlyBeneficialPodcast

Substack: https://open.substack.com/pub/clearlybeneficialpodcast

Website: www.clearhcs.com